Skip to content
Open Data Finder
Open Government Canada

Notice - Prescription Drug List (PDL): Mometasone furoate

Published by Health Canada | Santé Canada

About this dataset

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to allow the nonprescription use of Mometasone furoate for the conditions listed below. Only the Human part of the PDL was revised.

Notice - Prescription Drug List (PDL): Mometasone furoate · Open Data Finder